IN2012DN01225A - - Google Patents

Info

Publication number
IN2012DN01225A
IN2012DN01225A IN1225DEN2012A IN2012DN01225A IN 2012DN01225 A IN2012DN01225 A IN 2012DN01225A IN 1225DEN2012 A IN1225DEN2012 A IN 1225DEN2012A IN 2012DN01225 A IN2012DN01225 A IN 2012DN01225A
Authority
IN
India
Prior art keywords
active ingredient
polyisobutylene
layer
fentanyl
plasticizer
Prior art date
Application number
Other languages
English (en)
Inventor
Nouha Salman
Bjorn Schurad
Ingo Teutsch
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41559211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN01225(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino Ag filed Critical Acino Ag
Publication of IN2012DN01225A publication Critical patent/IN2012DN01225A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN1225DEN2012 2009-09-14 2010-09-14 IN2012DN01225A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09170223A EP2295046B1 (fr) 2009-09-14 2009-09-14 Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
PCT/EP2010/063433 WO2011029948A2 (fr) 2009-09-14 2010-09-14 Système thérapeutique transdermique pour l'administration de fentanyle ou d'un analogue du fentanyle

Publications (1)

Publication Number Publication Date
IN2012DN01225A true IN2012DN01225A (fr) 2015-04-10

Family

ID=41559211

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1225DEN2012 IN2012DN01225A (fr) 2009-09-14 2010-09-14

Country Status (10)

Country Link
US (1) US20120209223A1 (fr)
EP (2) EP2295046B1 (fr)
JP (1) JP2013504546A (fr)
CN (1) CN102548546A (fr)
AU (1) AU2010294160A1 (fr)
BR (1) BR112012005629A2 (fr)
CA (1) CA2773008A1 (fr)
IN (1) IN2012DN01225A (fr)
MX (1) MX2012002727A (fr)
WO (1) WO2011029948A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5558074B2 (ja) * 2009-10-15 2014-07-23 日東電工株式会社 塗膜保護シート
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
EP2599478A1 (fr) * 2011-11-30 2013-06-05 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
US9072682B2 (en) * 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
EP3250258A4 (fr) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Procédés et systèmes d'administration de médicament
WO2016145373A1 (fr) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Système d'entrée d'état de manque et de support
CN104825426A (zh) * 2015-05-26 2015-08-12 韩晓明 双相褪黑素贴剂
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
WO2018194879A1 (fr) * 2017-04-19 2018-10-25 Inep Europe Sarl Procédé de fabrication d'un timbre transdermique de fentanyl avec distribution uniforme de cristaux de médicament
US10377114B2 (en) * 2017-04-20 2019-08-13 Inep Europe Sarl Method for making a transdermal fentanyl patch with even drug crystal distribution
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CN111419827B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种阿芬太尼透皮给药的药物组合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US20010033858A1 (en) * 2000-02-29 2001-10-25 Jie Zhang Transdermal drug patch
US20030026829A1 (en) 2001-03-16 2003-02-06 Venkatraman Subramanian S. Transdermal administration of fentanyl and analogs thereof
WO2004024155A1 (fr) 2002-09-13 2004-03-25 Hisamitsu Pharmaceutical Co., Inc. Pastille adhesive
TWI296531B (en) 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
CN1640387A (zh) * 2004-01-15 2005-07-20 财团法人工业技术研究院 经皮吸收贴片及其制造方法
US9205062B2 (en) * 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
DE602004017164D1 (de) 2004-08-09 2008-11-27 Deutsches Krebsforsch Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP2042174B1 (fr) * 2006-07-14 2017-12-13 Hisamitsu Pharmaceutical Co., Inc. Préparation d'adhésif

Also Published As

Publication number Publication date
EP2295046B1 (fr) 2012-12-19
CA2773008A1 (fr) 2011-03-17
BR112012005629A2 (pt) 2016-08-02
CN102548546A (zh) 2012-07-04
WO2011029948A2 (fr) 2011-03-17
WO2011029948A3 (fr) 2011-10-13
MX2012002727A (es) 2012-05-08
EP2477616A2 (fr) 2012-07-25
EP2295046A1 (fr) 2011-03-16
US20120209223A1 (en) 2012-08-16
EP2477616B1 (fr) 2013-08-14
JP2013504546A (ja) 2013-02-07
AU2010294160A1 (en) 2012-04-05

Similar Documents

Publication Publication Date Title
IN2012DN01225A (fr)
MY163809A (en) Transdermal drug delivery system containing donepezil
MY183873A (en) Transdermal therapeutic system for application of an agent
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
WO2011076621A3 (fr) Système thérapeutique transdermique servant à administrer de la rivastigmine ou ses dérivés
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
MX347195B (es) Sistema de administración transdérmica de fármacos y método para usar el mismo.
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
EA200801575A1 (ru) Трансдермальная доставка мептазинола
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
IN2014DN09817A (fr)
MX2012008381A (es) Tira dental para administracion de tratamiento oral.
EP3513789A3 (fr) Agents prophylactiques et thérapeutiques pour maladies fgfr3
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
EA201391689A1 (ru) Система доставки лекарственного средства
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
AU2014203502B2 (en) Once-a-day replacement transdermal administration of fentanyl
NZ595549A (en) Transdermal therapeutic system containing nicotine
WO2012111996A3 (fr) Administration transdermique contenant de la galantamine ou ses sels
BR112012014107B8 (pt) sistema terapêutico transdérmico (tts) e processo de produção de tts
WO2016149077A3 (fr) Système d'administration transdermique de fentanyl
MX2021012709A (es) Sistema terapeutico transdermico.